Elekta
66,85 SEK -0,67%9 investorer følger denne virksomhed
Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.
Omsætning
-
EBIT %
-
P/E
19,6
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EKTA B
Daglig lav / høj pris
66,4 / 67,4
SEK
Markedsværdi
25,64 mia. SEK
Aktieomsætning
76,46 mio. SEK
Volumen
1,1 mio.
Finanskalender
Delårsrapport
24.08.2024
Generalforsamling
05.09.2024
Halvårligt udbytte
06.09.2024
Delårsrapport
27.11.2024
Delårsrapport
21.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Fjärde AP-fonden | 9,1 % | 6,7 % |
Laurent Leksell fam och bolag | 5,7 % | 30,2 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Elekta's Annual Report for 2023/24 available
Elekta to become new issuer in the Swedish commercial paper market
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools